Riboflavin has been studied in 89 papers since 2016: 1 trial and 66 observational studies in people, 6 in animals, 7 in cells, 9 reviews; 22 in the past year. The newest story, Nov 16, 2026: “Chemical mixture linked to faster biological aging in adults”.
A fly study reports lifespan extension with riboflavin, but lifespan shortens at 10 and 100 mg/mL. Independent labs link human dietary intake with less cognitive impairment; another study links it with higher cognitive dysfunction risk. Most registered trials—none classified as aging trials—ended over a year ago without posted results. Some authors have company affiliations, and some trials have company sponsors.
43 findings in 35 papers from 2016 to 2026, 6 of them since May 2026
Independent labs found the same change in worms or flies and people. 30 independent labs in 10 countries; 33 trials, none about aging, 21 with no results posted.
“Higher intakes of antioxidant vitamins, riboflavin, and folate were associated with 20% and 19% reduced intact AAA incidence, respectively.”
Worms or flies and humans: replicated by independent labs. Cells and mice: a single group.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Against: findings that point the other way from most findings on the same outcome.
About aging: the drug’s trials about aging. The total counts its trials for every use.
No results posted: trials that ended over a year ago with no results on ClinicalTrials.gov and no paper reporting them.
Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.
30 independent labs in 10 countries
5 findings against
33 trials, none about aging, 21 with no results posted
Funders: National Natural Science Foundation of China and others
Riboflavin is linked with a lower risk of cognitive impairment in humans (highest vs lowest quartile of dietary intake, mutually adjusted for other B vitamins) (OR 0.82 (0.69, 0.97), highest vs lowest quartile).
Humanshighest vs lowest quartile of dietary intake, mutually adjusted for other B vitaminsdietary intakeaverage 20 years follow-up
Riboflavin is linked with a lower risk of hypertension in humans (highest vs lowest quartile of dietary intake) (OR 0.51 (95% CI 0.32–0.81), Q4 vs Q1).
Humanshighest vs lowest quartile of dietary intakedietary intake
Riboflavin is associated with KDM biological age acceleration in humans (Attenuation of positive associations with PFHxS and the mixture of six key EDCs).
HumansAttenuation of positive associations with PFHxS and the mixture of six key EDCshigher intake
In 6,553 adults, combined exposure to six chemicals was linked to biological age acceleration, with an odds ratio of 1.58.In 6,553 adults, combined exposure to six chemicals was linked to biological age acceleration, with an odds ratio of 1.58.
Experiments in male and female mice found that 16 hours of fasting shifted a vitamin-binding protein toward cone cells without changing its total amount.Experiments in male and female mice found that 16 hours of fasting shifted a vitamin-binding protein toward cone cells without changing its total amount.